8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Analyze analyst forecasts for the company and compare them with competitors.
826.15B
The estimated revenue has increased from the previous period.
49.48B
The estimated EBITDA has increased from the previous period.
294.34
The estimated EPS has increased from the previous period.
23.32B
The estimated net income has increased from the previous period.
32.89B
The estimated EBIT has increased from the previous period.
116.90B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
1.49T
Revenue has increased from the previous period.
9.07%
Revenue growth rate is unchanged from the previous period.
89.22B
EBITDA has increased from the previous period.
5.99%
EBITDA margin is unchanged from the previous period.
59.30B
EBIT has increased from the previous period.
3.98%
EBIT margin is unchanged from the previous period.
29.92B
Depreciation has increased from the previous period.
92.70B
Total cash has increased from the previous period.
6.22%
Cash percentage is unchanged from the previous period.
4.10B
Receivables have increased from the previous period.
0.27%
Receivables percentage is unchanged from the previous period.
128.81B
Inventories have increased from the previous period.
8.65%
Inventory percentage is unchanged from the previous period.
282.60B
Accounts payable has increased from the previous period.
18.97%
Payables percentage is unchanged from the previous period.
-73.16B
Capital expenditure has increased from the previous period.
-4.91%
CapEx percentage is unchanged from the previous period.
5.07%
WACC is unchanged from the previous period.
5.18%
Cost of equity is unchanged from the previous period.
3.99%
Cost of debt is unchanged from the previous period.
0.25
Beta is unchanged from the previous period.
79.24M
Diluted shares outstanding is unchanged from the previous period.
34.06B
Total debt is unchanged from the previous period.
696.60B
Total equity is unchanged from the previous period.
730.66B
Total capital is unchanged from the previous period.
4.66%
Debt weighting is unchanged from the previous period.
95.34%
Equity weighting is unchanged from the previous period.
42.23B
EBIAT has increased from the previous period.
11.44B
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
379.47B
Terminal value is unchanged from the previous period.
352.79B
Enterprise value is unchanged from the previous period.
-18.24B
Net debt is unchanged from the previous period.
371.03B
Equity value is unchanged from the previous period.
4682.41
Equity value per share is unchanged from the previous period.
